HONG KONG - Researchers from the Riken Institute in Japan have discovered a mechanism through which the enteric Enterobacteriaceae bacteria can adjust to the very different oxygen environments within and outside of the human gut, an important finding that could represent a new drug target and ultimately lead to the development of new antimicrobials.